Eui H. Jung

Goyang, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Intravesical mitomycin-C administered immediately before transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: Clinical outcomes and molecular predictors from over 3 years of extended follow-up in a phase II trial.

Intravesical mitomycin-C administered immediately before transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: Clinical outcomes and molecular predictors from over 3 years of extended follow-up in a phase II trial.

Journal: Investigative and clinical urology
Published: March 03, 2026

Treatment strategies for cisplatin-ineligible metastatic bladder cancer: Emerging therapies and future perspectives.

Treatment strategies for cisplatin-ineligible metastatic bladder cancer: Emerging therapies and future perspectives.

Journal: Investigative and clinical urology
Published: July 09, 2025

Real-World Efficacy of Intravesical Gemcitabine for BCG-Unresponsive Non-muscle-Invasive Bladder Cancer.

Real-World Efficacy of Intravesical Gemcitabine for BCG-Unresponsive Non-muscle-Invasive Bladder Cancer.

Journal: Cancer research and treatment
Published: January 23, 2025

Exploring radiotherapy combined with a radiosensitizer for Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer with carcinoma in situ.

Exploring radiotherapy combined with a radiosensitizer for Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer with carcinoma in situ.

Journal: Translational andrology and urology
Published: September 09, 2024

Long-term efficacy of two sequential induction courses of Bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Long-term efficacy of two sequential induction courses of Bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Journal: Translational andrology and urology
Published: September 03, 2024

Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes.

Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes.

Journal: Archives of pharmacal research
Published: June 16, 2022

Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder.

Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder.

Journal: Biomedicines
Published: April 23, 2022

Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients.

Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients.

Journal: Archives of pharmacal research
Published: October 30, 2021

Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism.

Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism.

Journal: Archives of pharmacal research
Published: July 15, 2021

Correction to: Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects.

Correction to: Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects.

Journal: Archives of pharmacal research
Published: January 30, 2021

Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes.

Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes.

Journal: Archives of pharmacal research
Published: November 18, 2020

ABCB1 c.2677G>T/c.3435C>T diplotype increases the early-phase oral absorption of losartan.

ABCB1 c.2677G>T/c.3435C>T diplotype increases the early-phase oral absorption of losartan.

Journal: Archives of pharmacal research
Published: November 16, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026